PTLA
Macquarie Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-163,578
| Closed | -$2.94M | – | 2392 |
|
|
2020
Q2 | $2.94M | Sell |
163,578
-335,888
| -67% | -$6.04M | 0.01% | 909 |
|
|
2020
Q1 | $3.56M | Sell |
499,466
-70,968
| -12% | -$506K | 0.01% | 791 |
|
|
2019
Q4 | $13.6M | Buy |
570,434
+21,752
| +4% | +$519K | 0.02% | 594 |
|
|
2019
Q3 | $14.7M | Buy |
548,682
+43,469
| +9% | +$1.17M | 0.02% | 520 |
|
|
2019
Q2 | $13.7M | Sell |
505,213
-43,066
| -8% | -$1.17M | 0.02% | 544 |
|
|
2019
Q1 | $19M | Sell |
548,279
-37,299
| -6% | -$1.29M | 0.03% | 474 |
|
|
2018
Q4 | $11.4M | Buy |
585,578
+205,220
| +54% | +$4.01M | 0.02% | 573 |
|
|
2018
Q3 | $10.1M | Buy |
380,358
+207,358
| +120% | +$5.52M | 0.02% | 642 |
|
|
2018
Q2 | $6.53M | Buy |
+173,000
| New | +$6.53M | 0.01% | 721 |
|
|
2017
Q1 | – | Sell |
-39,201
| Closed | -$880K | – | 1585 |
|
|
2016
Q4 | $880K | Hold |
39,201
| – | – | ﹤0.01% | 1190 |
|
|
2016
Q3 | $890K | Sell |
39,201
-32,099
| -45% | -$729K | ﹤0.01% | 1176 |
|
|
2016
Q2 | $1.68M | Buy |
71,300
+45,100
| +172% | +$1.06M | ﹤0.01% | 1184 |
|
|
2016
Q1 | $534K | Sell |
26,200
-18,621
| -42% | -$380K | ﹤0.01% | 1224 |
|
|
2015
Q4 | $2.31M | Buy |
44,821
+581
| +1% | +$29.9K | ﹤0.01% | 901 |
|
|
2015
Q3 | $1.89M | Sell |
44,240
-23,572
| -35% | -$1M | ﹤0.01% | 985 |
|
|
2015
Q2 | $3.09M | Buy |
67,812
+36
| +0.1% | +$1.64K | 0.01% | 901 |
|
|
2015
Q1 | $2.57M | Buy |
67,776
+3,292
| +5% | +$125K | 0.01% | 949 |
|
|
2014
Q4 | $1.83M | Buy |
64,484
+4,301
| +7% | +$122K | ﹤0.01% | 1041 |
|
|
2014
Q3 | $1.52M | Buy |
60,183
+353
| +0.6% | +$8.92K | ﹤0.01% | 1070 |
|
|
2014
Q2 | $1.75M | Buy |
59,830
+1,412
| +2% | +$41.2K | ﹤0.01% | 1084 |
|
|
2014
Q1 | $1.51M | Buy |
58,418
+4,735
| +9% | +$123K | ﹤0.01% | 1086 |
|
|
2013
Q4 | $1.38M | Buy |
+53,683
| New | +$1.38M | ﹤0.01% | 1082 |
|